VERX logo

VERXVertex Inc - Ordinary Shares Class A

$12.11
$0.68
(5.32%)
Today
Closed $12.11
$0.11
(0.91%)
After Hours
Updated: 06:55 PM EDT
EarningsAug 5
Mkt Cap$2.07B
Vol1.41M
News
all
press releases
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now?
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now...
Yahoo! Finance: News
News Placeholder
More News
News Placeholder
Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders
Vertex Reports CASGEVY Data Showing Sustained Benefits In Children With Sickle Cell Disease And Beta Thalassemiaread more...
Benzinga
News Placeholder
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
Key PointsKyverna Therapeutics is a clinical-stage biopharmaceutical firm advancing cell therapies for autoimmune diseases...
Nasdaq News: Markets
News Placeholder
Analyst Report: Vertex Pharmaceuticals Inc
Analyst Report: Vertex Pharmaceuticals Inc...
Yahoo! Finance: News
News Placeholder
Vertex (VERX) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
read more...
Benzinga
News Placeholder
Compared to Estimates, Vertex (VERX) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Vertex (VERX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
News Placeholder
Vertex (VERX) Tops Q1 Earnings and Revenue Estimates
Vertex (VERX) delivered earnings and revenue surprises of +5.13% and +1.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Biotech Stocks To Add to Your Watchlist - May 6th
Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...
MarketBeat
News Placeholder
QRG Capital Management Inc. Increases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX
QRG Capital Management Inc. increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 18,396 shares of the pharmaceutical company's stock after...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.